According to a new study, there are additional barriers to recruiting women for cardiovascular research. This is despite the fact that women die from heart disease at a higher rate than men.
Between 2010 and 2017, 740 cardiovascular clinical trials were reviewed as part of the study.
It was later discovered that women make up 38% of all participants.
Dr. Jeske van Diemen of Amsterdam University Medical Centre in the Netherlands, who is also one of the study’s co-authors, stated that changing this is “not as simple as it sounds.”
Van Diemen and her colleagues examined the evidence behind the motivators and concluded that it is still unclear why women’s participation rates are so low.
The researchers looked for barriers to trial participation, according to the paper published in the European Heart Journal. As a result, they discovered six studies that met their criteria, with a total of 846 men and 1,122 women.
However, both sexes identified time constraints and the possibility of unfavorable outcomes as barriers. In comparison to men, women appeared to perceive a higher risk of harm from participation. Transport constraints were also cited as a reason for declining trial participation more frequently.
According to Van Diemen, it is unclear why trial risk perceptions differ between sexes, but “women more often have barriers that make it difficult to attend follow-up appointments, such as not having a driving licence or caring for grandchildren.”